IPPRA / Grant Monitor

2026-07-07
← Board

DoW Bone Marrow Failure, Investigator-Initiated Research Award

HT942526BMFRPIIRA · Defense Health Agency Contracting Activity - DHACA

biomedical clinical public health Science & Technology R&D

Closes
2026-11-04 · 120 d
Award ceiling
Award floor
Program funding
$1,250,000
Expected awards
1
Cost sharing
No
Posted
2026-06-17
Instrument
Grant
Characterization · gpt-5.4-mini · 2026-07-07

Supports investigator-initiated studies advancing bone marrow failure research and related patient care, including translational research, preclinical and human-subjects research, correlative studies, and IND-enabling activities, but not clinical trials.

Funds
applied research
University
direct
social behavioral
minor
physical sciences
minor
engineering
minor
life biomedical
central
computational data
minor

⚑ Requires preliminary data. · Partnering PI allowed; only initiating PI submits pre-application, but both PIs submit full applications. · Associated applications for a project may be withdrawn if initiating or partnering application is rejected or administratively withdrawn. · Clinical trials are not allowed.

Unit fits — one characterization, each unit's own rules

IPPRA 58 good peripheral portfolio topic: public_health; social/behavioral work is minor; funds applied research; biomedical core — IPPRA health lane is communication/crisis/policy (capped); clinical-trial/biomedical core — IPPRA angle is policy/community (capped)
Physical Sciences & Engineering (demo) 55 good technical depth: minor; funds applied research
Tom Love Innovation Hub 30 weak funds applied research; deep-tech content

Description

Summary: Supports studies that further develop mature ideas, expand upon key discoveries, and have the potential to make significant advances in bone marrow (BMF) failure research and/or patient care. Investigator-Initiated Research Award (IIRA) applications may involve translational and clinical research including studies in preclinical models, research with human data and/or anatomical substances, and research with human subjects, as well as correlative studies associated with a clinical trial(s); however, this award mechanism does not support clinical trials. IIRA applications may also support Investigational New Drug (IND)-enabling efforts such as lead compound characterization, and assessments of formulation and stability, absorption, distribution, metabolism and excretion, dose/response and toxicology.

Distinctive Features:

This funding mechanism allows for a partnering Principal Investigator (PI). Only the initiating PI will submit a pre-application, but both PIs will need to submit full applications. The partnering PI application is an abbreviated package specific to their distinct portion of the research project. Be advised, all associated applications for a research project may be withdrawn if the initiating or partnering application is rejected or administratively withdrawn.

This award mechanism requires preliminary data relevant to the proposed project. Applications can support clinical research studies; however, this mechanism does not allow clinical trials.

Apply

View on Grants.gov → CONTACT: Christopher L Baker Grants Officer <help@eBRAP.org>

Proposal brief SEE AN EXAMPLE →

A one-page internal memo: fit assessment, submission requirements, document scaffold, and next steps dated back from the deadline — tailored to your project idea if you add one.

ONE LLM CALL (~1¢) · CACHED · REQUIRES STAFF KEY

Proposal shell · Department of Defense (BAA-style) conventions SEE A DOD EXAMPLE →

Funder-faithful document skeletons — Department of Defense (BAA-style)'s document set with section headings, page limits, reviewer guidance, and writing prompts; add a project idea to get [DRAFT] starter bullets. Download as .md for Word or Overleaf.

ONE LLM CALL (~2-3¢) · CACHED · SCAFFOLDING, NOT GHOSTWRITING